Angion Completes Equity Financing and Appoints Senior Executives
Closes $35 million financing to advance Phase 2 and Phase 3 programs with drug candidate ANG-3777 Announces appointments of Jay R. Venkatesan, M.D. as President and Chief Executive Officer, and John F. Neylan, M.D. as Senior Vice President and Chief …